Erythromycin attenuates an experimental model of chronic bronchiolitis via augmenting monocyte chemoattractant protein-1

European Respiratory Journal

Volumn 17, Issue 3, 2001, Pages 360-367

  Takahashi, T ^a   Suga, M ^a   Matsukawa, A ^a   Sato, K ^a   Okamoto, T ^a   Ichiyasu, H ^a   Ohkawara, S ^a   Yoshinaga, M ^a   Ando, M ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Bronchiolitis; Erythromycin; Monocyte chemoattractant protein 1; Pseudomonas aeruginosa

Indexed keywords

ERYTHROMYCIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; BRONCHIOLITIS; CELL VIABILITY; CHRONIC DISEASE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; GRANULOMATOSIS; IMMUNOHISTOCHEMISTRY; INOCULATION; LEUKOCYTE COUNT; LIQUID; LUNG INFECTION; LUNG LAVAGE; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PSEUDOMONAS AERUGINOSA; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAGING;

ANIMALS; BRONCHIOLITIS; CHEMOKINE CCL2; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; ERYTHROMYCIN; MALE; RABBITS;

EID: 0034948577     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.01.17303600     Document Type: Article

References (30)

1. Pathologic manifestations of bronchiolitis, constrictive bronchiolitis, cryptogenic organizing pneumonia, and diffuse panbronchiolitis
2. Diffise panbronchiolitis
3. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin
4. Erythromycin treatment in diffuse panbronchiolitis
5. Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis
6. Erythromycin and diffuse panbronchiolitis
7. Erythromycin inhibition of lipopolysaccharide-stimulated tumor necrosis factor alpha production by human monocytes in vitro
8. Mechanism of efficacy of erythromycin on diffuse panbronchiolitis-effect of erythromycin on cytokine mRNA expression in human whole blood model
9. Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases
10. Significance of IL-1 beta and IL-1 receptor antagonist (IL-1Ra) in bronchoalveolar lavage fluid (BALF) in patients with diffuse panbronchiolitis (DPB)
11. Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: A potential mechanism of macrolide therapy
12. Monocyte chemoattractant protein 1: A potential regulator of monocyte recruitment in inflammatory disease
13. Monocyte Chemoattractant Protein-1
14. A rat model of chronic respiratory infection with Pseudomonas aeruginosa
15. Efficacy of erythromycin lactobionate for treating Pseudomonas aeruginosa bacteremia in mice
16. Production and regulation of MCP-1 in lipopolysaccharide-or monosodium urate crystal-induced arthritis in rabbits: Role of TNFα, IL-1 and IL-8
17. Role of T cells in bronchoalveolar space in the development of interstitial pneumonia induced by superantigen in autoimmune-prone mice
18. Production of IL-1 and IL-1 receptor antagonist and the pathological significance in lipopolysaccharide-induced arthritis in rabbits
19. Neutrophil accumulation and activation by homologous IL-8 in rabbits. IL-8 induces destruction of cartilage and production of IL-1 and IL-1 receptor antagonist in vivo
20. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor
21. Interleukin-8 and the chemokine family
22. Chemokines, a family of chemotactic cytokines
23. Role of pro- and anti-inflammatory cytokines during inflammation: Experimental and clinical findings
24. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line
25. Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes
26. Protection against lethal bacterial infection in mice by monocyte-chemotactic and -activating factor
27. MCP-1 protects mice in lethal endotoxemia
28. Differential CC chemokine-induced enhancement of T helper cell cytokine production
29. C-C chemokines differentially alter interleukin-4 production from lymphocytes
30. Costimulation of fibroblast collagen and transforming growth factor beta 1 gene expression by monocyte chemoattractant protein-1 via specific receptors